Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India.

Burza, S; Sinha, PK; Mahajan, R; Lima, MA; Mitra, G; Verma, N; Balasegaram, M; Balsegaram, M; Das, P; (2014) Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India. PLoS neglected tropical diseases, 8 (1). e2536. ISSN 1935-2727 DOI: https://doi.org/10.1371/journal.pntd.0002536

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1371/journal.pntd.0002536

Abstract

Share

Download

Filename: Risk Factors for Visceral_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar